IGF-1
Insulin-like Growth Factor 1, Somatomedin C
A 70-amino acid hormone that promotes cell growth, proliferation, and survival, primarily produced in the liver in response to growth hormone stimulation.
Completed
NA
NCT02357498
Transsphenoidal Extent of Resection Study
St. Joseph's Hospital and Medical Center, Phoenix
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT03511092
The Effects of Leucine Metabolites in Performance, Body Composition and Biochemical Markers of Muscle Damage
Faculdade de Motricidade Humana
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT06380777
Establishment and Application of Digital Diagnosis and Treatment System for Sarcopenia
Peking Union Medical College Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Terminated
PHASE1, PHASE2
NCT00490100
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT05621109
PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Copenhagen
Christian Mølgaard
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02137538
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
Stanford University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00166725
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
Novartis
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01973244
A Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (Somapacitan) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Withdrawn
PHASE1
NCT04021017
PRE-GAiN Bone Health Pilot Study
University of Saskatchewan
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05330325
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00001669
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients
National Institute of Neurological Disorders and Stroke (NINDS)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT01502137
Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00719212
Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer
Translational Research in Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE3
NCT03252353
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
Chiasma, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT07108413
Study of the Cognitive and Neurophysiological Effects of the Activ4Brain Program for Older Adults
University of Coimbra
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1
NCT00474760
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
Pfizer
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT00612560
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
Roswell Park Cancer Institute
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT01724489
Study of Growth Hormone and Bone in Obesity
Massachusetts General Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NCT04530214
Predictive Elements of Trauma and Its After-effects: Importance of the Quality of Neurobiological Response to Stress
Direction Centrale du Service de Santé des Armées
OBSERVATIONAL
Updated Dec 15, 2025
Completed
NA
NCT00522743
Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.
Rabin Medical Center
INTERVENTIONAL
Updated Dec 15, 2025